Function
Locations
Decarboxylates ornithine to putrescine (rate-limiting).
The polyamines putrescine, spermidine and spermine are small polycationic metabolites essential for cell growth, chromatin and nucleic-acid stabilisation, ion-channel regulation and translation (spermidine is also the precursor of the eIF5A hypusine modification). Their intracellular levels are held under exceptionally tight homeostatic control by a biosynthetic arm, a catabolic/back-conversion arm and a dedicated feedback regulatory system. Biosynthesis begins with ornithine decarboxylase (ODC1), the rate-limiting, PLP-dependent enzyme that decarboxylates L-ornithine to putrescine. In parallel, the pyruvoyl-dependent S-adenosylmethionine decarboxylase (AMD1) produces decarboxylated SAM (dcSAM), the aminopropyl-group donor. Spermidine synthase (SRM) then transfers an aminopropyl group from dcSAM to putrescine to make spermidine, and spermine synthase (SMS) adds a further aminopropyl group to make spermine (each step releasing 5'-methylthioadenosine). Catabolism proceeds mainly by back-conversion: spermidine/spermine N1-acetyltransferase (SAT1) N1-acetylates spermine and spermidine using acetyl-CoA, and the peroxisomal FAD oxidase PAOX oxidises these N1-acetyl polyamines back to spermidine and putrescine (releasing H2O2 and 3-acetamidopropanal); spermine oxidase (SMOX) provides a parallel, acetylation- independent route that oxidises free spermine directly to spermidine. Overlaying all of this is the antizyme feedback loop: ornithine decarboxylase antizyme (OAZ1) — itself translated via a polyamine- stimulated +1 ribosomal frameshift — binds ODC1, inhibits it and targets it for ubiquitin-independent 26S proteasomal degradation while also suppressing polyamine uptake; antizyme inhibitor (AZIN1), a catalytically dead ODC homolog, binds and sequesters antizyme to release active ODC1. Dysregulated polyamine metabolism drives cancer and several inherited disorders (ODC1 gain-of-function Bachmann-Bupp syndrome; SMS-deficiency Snyder-Robinson syndrome; SAT1 overactivity).
All recommended fields populated.
✗ none found
No MODULE:polyamine_metabolism deep-research report alongside the module YAML.
✓ every leaf node grounds to a representative protein.
✓ every declared conforms_to bundle matches its template motif.
9 complete review(s) · 0 with deep research · 0 missing review · 9 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| AMD1 P17707 | ✓ | ✓ | ✗ |
| AZIN1 O14977 | ✓ | ✓ | ✗ |
| OAZ1 P54368 | ✓ | ✓ | ✗ |
| ODC1 P11926 | ✓ | ✓ | ✗ |
| PAOX Q6QHF9 | ✓ | ✓ | ✗ |
| SAT1 P21673 | ✓ | ✓ | ✗ |
| SMOX Q9NWM0 | ✓ | ✓ | ✗ |
| SMS P52788 | ✓ | ✓ | ✗ |
| SRM P19623 | ✓ | ✓ | ✗ |
Polyamine metabolism (GO:0006596 biosynthesis + GO:0006598 catabolism), grounded to nine completed human gene reviews. BIOSYNTHESIS (cytosol): ODC1 (P11926 PTHR11482, GO:0004586 PLP, ornithine-> putrescine, rate-limiting) + AMD1 (P17707 PTHR11570, GO:0004014 pyruvoyl, SAM->dcSAM donor) -> SRM (P19623 PTHR11558, GO:0004766, putrescine->spermidine) -> SMS (P52788 PTHR46315, GO:0016768, spermidine->spermine); each aminopropyl transfer releases MTA. CATABOLISM/back-conversion: SAT1 (P21673 PTHR10545, GO:0004145 acetyl-CoA N1-acetyltransferase, rate-limiting) -> peroxisomal PAOX (Q6QHF9 PTHR10742, GO:0052903 FAD, oxidises N1-ACETYL polyamines); plus SMOX (Q9NWM0, same PTHR10742 family, GO:0052901 FAD) which oxidises FREE spermine directly (SMOX and PAOX share the polyamine-oxidase family but differ in substrate acetylation state). REGULATION (the hallmark antizyme loop, modelled with `processes`): OAZ1 (P54368 PTHR10279, GO:0008073 ODC inhibitor activity; +1-frameshift polyamine sensor; binds ODC1, inhibits + targets it for ubiquitin-independent 26S degradation) NEGATIVELY_REGULATES ODC1; AZIN1 (O14977, catalytically-DEAD ODC homolog sharing PTHR11482 with ODC1, GO:0042978 ODC activator activity — NOT a decarboxylase) NEGATIVELY_REGULATES OAZ1 (antizyme sequestration), net-activating ODC1. Spermidine also feeds eIF5A hypusination (separate pathway). GO term ids/labels verified against the local go.db. Disorders: ODC1 gain-of-function Bachmann-Bupp syndrome; SMS-deficiency Snyder-Robinson syndrome; SAT1 overactivity; broad oncology relevance (ODC is a MYC target and DFMO drug target).
Decarboxylates ornithine to putrescine (rate-limiting).
Makes decarboxylated SAM (aminopropyl donor).
Aminopropylates putrescine to spermidine.
Aminopropylates spermidine to spermine.
N1-acetylates spermine/spermidine (commits to back-conversion).
Oxidises N1-acetyl polyamines to shorter polyamines (+ H2O2).
Oxidises free spermine directly to spermidine (+ H2O2).
Non-catalytic feedback regulator (GO:0008073 ODC inhibitor activity). Synthesised via a polyamine-stimulated +1 frameshift; binds ODC1, inhibits it and targets it for ubiquitin- independent 26S proteasomal degradation; also inhibits polyamine uptake.
Catalytically DEAD ODC homolog (no ornithine decarboxylase activity); GO:0042978 ODC activator activity. Binds antizyme (OAZ1) with higher affinity than ODC, sequestering it and releasing/stabilising active ODC1 — a positive regulator of polyamine synthesis.